PVI
NXTM

Pura Vida Investments’s NxStage Medical Inc. NXTM Stock Holding History

Pura Vida Investments’s Portfolio NXTM Stock Details NXTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-221,685
Closed -$5.56M – 107
2017
Q2 		$5.56M Sell
221,685
-53,315
-19% -$1.32M 2.21% 18
2017
Q1 		$7.38M Buy
275,000
+17,500
+7% +$483K 2.18% 16
2016
Q4 		$6.75M Sell
257,500
-107,500
-29% -$2.66M 2.47% 15
2016
Q3 		$9.12M Buy
365,000
+165,000
+83% +$3.85M 2.77% 5
2016
Q2 		$4.34M Sell
200,000
-40,157
-17% -$716K 1.84% 20
2016
Q1 		$3.6M Buy
240,157
+30,157
+14% +$505K 1.64% 24
2015
Q4 		$4.6M Sell
210,000
-100,000
-32% -$1.86M 1.94% 20
2015
Q3 		$4.89M Buy
310,000
+49,800
+19% +$798K 2.79% 9
2015
Q2 		$3.72M Buy
260,200
+156,084
+150% +$2.64M 1.9% 19
2015
Q1 		$1.8M Sell
104,116
-15,884
-13% -$281K 0.93% 40
2014
Q4 		$2.15M Buy
+120,000
New +$1.93M 0.79% 46

Other funds holding NXTM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.63% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 26.7% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
PCM
Pennant Capital Management Summit, New Jersey $212M AUM 19.37% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Pura Vida Investments's NXTM Position: Q3 2017 in Review

Pura Vida Investments sold out of NxStage Medical Inc. (NXTM) in Q3 2017, closing a stake of 221,685 shares — an estimated $5.56M sold.

Pura Vida Investments first reported a position in NXTM in Q4 2014 and held it in 11 quarters. The position peaked at $9.12M in Q3 2016. 168 funds tracked by Wall St. Rank hold NXTM as of Q3 2017.

  • Pura Vida Investments reported no remaining NxStage Medical Inc. position as of Q3 2017 after selling out during the quarter.
  • Pura Vida Investments sold 221,685 NxStage Medical Inc. shares in Q3 2017, an estimated $5.56M.
  • Pura Vida Investments first reported a position in NxStage Medical Inc. in Q4 2014 and held it in 11 quarters.
  • Pura Vida Investments's NxStage Medical Inc. position peaked at $9.12M in Q3 2016.
  • 168 funds tracked by Wall St. Rank held NxStage Medical Inc. as of Q3 2017.

Based on Pura Vida Investments's 13F filing for Q3 2017, filed 14 Nov 2017.